Spontaneous hemothorax caused by rivaroxaban treatment for pulmonary embolism: A case report
Bassem Al Hariri, Ahmad Taher Alharafsheh, Muad Abdi Hassan, Abdulqadir J. Nashwan, Mohamed Gaafar Mohamedali, Hatem Mabrouk Abusriwil · 2023
Read Spontaneous hemothorax caused by rivaroxaban treatment for pulmonary embolism: A case report by Bassem Al Hariri, Ahmad Taher Alharafsheh, Muad Abdi Hassan, Abdulqadir J. Nashwan, Mohamed Gaafar Mohamedali, Hatem Mabrouk Abusriwil (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10714055.txt.
Description
Al Hariri and colleagues report in 2023 a case of spontaneous hemothorax, blood filling the chest cavity, in a patient treated with rivaroxaban for a lung blood clot. Hemothorax is rare and can be fatal, and blood thinners are among its known causes. Newer oral anticoagulants bleed less than older vitamin K drugs overall. Still, some researchers suspect their bleeding episodes can be worse when they happen.
The team argues the timing supports a genuine link between the drug and this bleed. The case reminds clinicians that even safer anticoagulants demand vigilance for hidden bleeding.
Catalog record
| CREATOR | Bassem Al Hariri, Ahmad Taher Alharafsheh, Muad Abdi Hassan, Abdulqadir J. Nashwan, Mohamed Gaafar Mohamedali, Hatem Mabrouk Abusriwil |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 10 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |